Remove Extraction Remove Pharmaceutical Remove Treatment
article thumbnail

The Cannabis Cancer Connection

Project CBD

United Kingdom-based GW Pharmaceuticals has produced the world’s first approved cannabis-based medicines for the UK, US, and European markets, Sativex® and Epidiolex®. GW Pharmaceuticals’ research on glioblastoma multiforme (GBM) is important and promising. Note: In May 2021, GW Pharmaceuticals was acquired by Jazz Pharmaceuticals.]

article thumbnail

Press Release: This is the FIRST Public Psychedelics Company to Notch a Patent for Extracting Natural Psilocybin

Cannabis Law Report

Psychedelics are quickly emerging as alternative methods of treatment for mental illnesses and neurodegenerative conditions — particularly in countries such as Canada. Additionally, the technology backed by the patent will be essential for transforming variable psychedelic raw materials into pharmaceutical-grade standardized extracts.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

However, there are indications from studies done with cannabidiol-rich cannabis extracts in Israel that indicate that less side effects (46%) are achieved with a natural cannabis plant extract containing a 20:1 ratio of CBD to THC. Introduction: Recently, a formulation of cannabidiol was approved by the United States FDA.

article thumbnail

Dr. Andrew Weil on Cannabis and Integrative Medicine

Project CBD

In general, I think that botanical medicine is safer than pharmaceutical medicine, that the chances of causing harm are much less. And then cannabis has unique effects for a wide range of conditions, everything from the treatment of pain, treatment of asthma, treatment of immune conditions.

Medicine 306
article thumbnail

Medical Marijuana is Being Used to Treat Dementia With Success

FloridaMarijuana.net

The Dementia Society of America attributes Dementia to rising healthcare costs as billions are spent each year for treatments and research. Pharmaceutical treatments for for Dementia often only target symptoms like pain or depression, but those medicines do not cure or prevent the disease. 9-tetrahydrocannabinol (?9-THC)

article thumbnail

New Research Shows Promising Treatment Results for Migraine Sufferers

Veriheal

Most of the conventional methods for treating migraines involve pharmaceutical medication, which has been known to be accompanied by unwanted side effects, especially from opioid based medication. If you have ever suffered through a migraine , you’ll know how much an effective alleviator is necessary. What Does the Study Have to Say?

article thumbnail

Valcon Medical A/S Announces Receipt of EU GMP Certification and Start of Commercial Production for Pharmaceutical-Grade Cannabis Concentrates, Intermediary Products, and Medical Formulations

Cannabis Law Report

Valcon Medical A/S Announces Receipt of EU GMP Certification and Start of Commercial Production for Pharmaceutical-Grade Cannabis Concentrates, Intermediary Products, and Medical Formulations (PRNewsfoto/Valcon Medical A/S). and BÜCHI Labortechnik AG, both leaders in cannabis production and processing services. About Valcon Medical.